CAPR
Capricor Therapeutics Inc
9.00$
+0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.5% | 86.6% | 83.8% | 80.1% | 92.3% | 95.8% | 95.1% | 92.9% | 79.8% | 90.7% | 86.8% | 65.7% | |
| 24.2% | 25.0% | 12.6% | 27.9% | 73.6% | 6.6% | 18.7% | 17.4% | 15.4% | 80.9% | 32.3% | 5.7% | |
| 76.8% | 67.2% | 80.7% | 77.0% | 91.5% | 88.9% | 94.2% | 91.9% | 78.0% | 89.4% | 85.4% | 64.5% | |
| 1.5% | 17.7% | 0.7% | 1.0% | 0.4% | 6.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 104.8% | 61.5% | 62.7% | 70.0% | 26.6% | 14.7% | 17.0% | 21.4% | 33.7% | 14.1% | 14.6% | 33.2% | |
| 88.6% | 53.2% | 53.4% | 58.4% | 22.0% | 12.3% | 14.5% | 21.3% | 22.3% | 10.1% | 10.3% | 8.9% | |
| 2.0% | 1.3% | 1.6% | 2.1% | 0.9% | 0.5% | 0.5% | 3.2% | 2.8% | 1.0% | 2.2% | 0.4% | |
| 18.3% | 10.6% | 12.6% | 16.1% | 7.0% | 1.9% | 3.4% | 3.6% | 2.2% | 0.5% | 1.2% | 0.8% | |
| -4.8% | 38.5% | 37.3% | 30.0% | 73.4% | 85.3% | 83.0% | 78.6% | 66.3% | 85.9% | 85.4% | 66.8% | |
| -426.9% | -271.3% | -342.1% | -470.7% | -207.3% | -117.2% | -145.8% | -187.3% | -217.3% | -85.7% | -103.8% | -102.9% | |
| 69.5% | 45.6% | 63.4% | 83.2% | 35.6% | 20.7% | 29.7% | 34.2% | 36.2% | 13.7% | 17.6% | 15.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.